Vaccine safety surveillance across the globe with a focus on the COVID-19 vaccines

Authors

  • Arunima Sen MMS Holding Inc., Bangalore, India Author

DOI:

https://doi.org/10.53411/jpadr.2021.2.3.1

Keywords:

CDC, AEIS, BEST, COVID-19, COWIN

Author Biography

  • Arunima Sen, MMS Holding Inc., Bangalore, India

    Director, Pharmacovigilance and Medical Writing.

References

Arlett, P. (2021). Safety monitoring of COVID-19 Vaccines, European medicines agency, 2021, 1-10.

FDA, Covid-19 Vaccine Safety Surveillance. Safety & Availability (Biologics), 2021; Accessed on July 12, 2021.

Joshi, J., Das, M. K., Polpakara, D., Aneja, S., Agarwal, M., & Arora, N. K. (2018). Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India. Indian journal of pediatrics, 85(2), 139–148.

Salman O, Topf K, Chandler R, Conklin L. (2021). Progress in Immunization Safety Monitoring — Worldwide, 2010–2019. MMWR Morb Mortal Wkly Rep,70, 547–551. Retrieved from https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/index.html

TGA (2021). Covid-19 Vaccine Safety monitoring plan. Australian Government, 1, 1-13.

Vaccine Centre, London School of Hygiene & Tropical Medicine, Retrieved from https://vaclshtm.shinyapps.io/ncov_vaccine_landscape/

Downloads

Published

2021-09-01

Issue

Vol. 2 No. 3 (2021): Journal of Pharmacovigilance and Drug Research

Section

Editorial

License

Copyright (c) 2021 Arunima Sen

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Vaccine safety surveillance across the globe with a focus on the COVID-19 vaccines. (2021). Journal of Pharmacovigilance and Drug Research, 2(3), 1-2. https://doi.org/10.53411/jpadr.2021.2.3.1

Most read articles by the same author(s)

Similar Articles

1-10 of 19

You may also start an advanced similarity search for this article.